Search Results for citation:"90 FR 10830"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 10830"

  • Type:Notice
    Citation:90 FR 10830
    Reading Time:about a minute or two

    Groff Hemplex LLC has applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of certain controlled substances. The company plans to use these substances for its own purposes and to sell them to approved research investigators. The public can submit comments or objections electronically by April 28, 2025, and also request a hearing on this application by the same date. This application process follows the regulations set by the DEA under 21 CFR 1301.33(a).

    Simple Explanation

    Groff Hemplex LLC wants permission from the government to make special kinds of medicines and sell them to scientists for research. People can tell the government what they think about this by April 28, 2025.

  • Type:Notice
    Citation:90 FR 10830
    Reading Time:about a minute or two

    The United States International Trade Commission (USITC) decided that if the antidumping duty orders on certain stilbenic optical brightening agents from China and Taiwan were removed, it would likely harm the U.S. industry in the near future. These reviews were reinstated after a court ordered a reevaluation following a previous decision to revoke these orders. The USITC completed their review and published their findings in a document dated February 21, 2025.

    Simple Explanation

    The people who check if stuff sold from other countries to America is fair (USITC) said that taking away extra charges (called antidumping duties) on a type of product from China and Taiwan might hurt the people who make similar stuff in America. They looked at the issue again after being told by a court to reconsider their earlier decision.